Skip to main content
Top
Published in: Medical Oncology 4/2009

01-12-2009 | Original Paper

Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach

Authors: Yan Chen, Can-E. Tang, Guo-Liang Ouyang, Lin Ruan, Mao-Yu Li, Peng-Fei Zhang, Cui Li, Hong Yi, Fang Peng, Jian-Ling Li, Zhu-Chu Chen, Zhi-Qiang Xiao

Published in: Medical Oncology | Issue 4/2009

Login to get access

Abstract

Aims To screen for differentially tyrosine-phosphorylated proteins between nasopharyngeal carcinoma (NPC) and normal nasopharyngeal epithelial tissues (NNET) to provide a basis for elucidate the molecular mechanisms of NPC carcinogenesis. Methods Two-dimensional (2-D) electrophoresis was applied to separate proteins from NPC and NNET, respectively, and 2-D Western blotting was performed to detect tyrosine-phosphorylated proteins using antiphosphotyrosine antibody. Differentially tyrosine-phosphorylated proteins were identified by electrospray ionization-quadrupole time-of-flight MS (ESI-Q-TOF MS). NetPhos software was used to predict the tyrosine-phosphorylation sites of the identified proteins, and Western blotting was used to detect the tyrosine-phosphorylated levels of RKIP in NPC and NNET. Results Twenty-five differentially tyrosine-phosphorylated proteins in the two types of tissues were found, 13 of which were identified by ESI-Q-TOF MS. Among the 13 identified proteins, tyrosine-phosphorylated levels of 7 proteins were increased, and those of 6 proteins were decreased in NPC compared with NNET. NetPhos software prediction showed that all the 13 identified proteins contained tyrosine phosphorylation sites, and the differentially tyrosine-phosphorylated level of RKIP in NPC and NNET was confirmed. Conclusion The 13 differentially tyrosine-phosphorylated proteins may be involved in the development and progression of NPC.
Literature
1.
go back to reference Yu MC. Nasopharyngeal carcinoma: epidemiology and dietary factors. IARC Sci Publ. 1991;105:39–47.PubMed Yu MC. Nasopharyngeal carcinoma: epidemiology and dietary factors. IARC Sci Publ. 1991;105:39–47.PubMed
3.
go back to reference Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol. 1994;21(3):382–97.PubMed Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol. 1994;21(3):382–97.PubMed
4.
go back to reference Dua K, Williams TM, Beretta L. Translational control of the proteome: relevance to cancer. Proteomics. 2001;1(10):1191–9. doi:10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8.CrossRefPubMed Dua K, Williams TM, Beretta L. Translational control of the proteome: relevance to cancer. Proteomics. 2001;1(10):1191–9. doi:10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8.CrossRefPubMed
5.
6.
go back to reference Soskic V, Gorlach M, Poznanovic S, et al. Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor. Biochemistry. 1999;38(6):1757–64. doi:10.1021/bi982093r.CrossRefPubMed Soskic V, Gorlach M, Poznanovic S, et al. Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor. Biochemistry. 1999;38(6):1757–64. doi:10.​1021/​bi982093r.CrossRefPubMed
8.
go back to reference Cheng AL, Huang WG, Chen ZC, et al. Identificating Cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res. 2008;7(6):2415–26. doi:10.1021/pr7008548.CrossRefPubMed Cheng AL, Huang WG, Chen ZC, et al. Identificating Cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res. 2008;7(6):2415–26. doi:10.​1021/​pr7008548.CrossRefPubMed
9.
go back to reference Xiao ZQ, Chen Y, Yi B, et al. Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis. Proteomics Clin Appl. 2007;1(7):688–98. doi:10.1002/prca.200600561.CrossRef Xiao ZQ, Chen Y, Yi B, et al. Identification of nasopharyngeal carcinoma antigens that induce humoral immune response by proteomic analysis. Proteomics Clin Appl. 2007;1(7):688–98. doi:10.​1002/​prca.​200600561.CrossRef
10.
go back to reference Patarca R. Protein phosphorylation and dephosphorylation in physiologic and oncologic processes. Crit Rev Oncog. 1996;7(5–6):343–432.PubMed Patarca R. Protein phosphorylation and dephosphorylation in physiologic and oncologic processes. Crit Rev Oncog. 1996;7(5–6):343–432.PubMed
11.
go back to reference Pandey A, Podtelejnikov AV, Blagoev B, et al. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc Natl Acad Sci U S A. 2000;97(1):179–84. doi:10.1073/pnas.97.1.179.CrossRefPubMed Pandey A, Podtelejnikov AV, Blagoev B, et al. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc Natl Acad Sci U S A. 2000;97(1):179–84. doi:10.​1073/​pnas.​97.​1.​179.CrossRefPubMed
12.
go back to reference Gronborg M, Kristiansen TZ, Stensballe A, et al. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics. 2002;1(7):517–27. doi:10.1074/mcp.M200010-MCP200.CrossRefPubMed Gronborg M, Kristiansen TZ, Stensballe A, et al. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics. 2002;1(7):517–27. doi:10.​1074/​mcp.​M200010-MCP200.CrossRefPubMed
18.
19.
go back to reference Ozeki M, Tamae D, Hou DX, et al. Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD. Anticancer Res. 2004;24(5A):2657–63.PubMed Ozeki M, Tamae D, Hou DX, et al. Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD. Anticancer Res. 2004;24(5A):2657–63.PubMed
Metadata
Title
Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach
Authors
Yan Chen
Can-E. Tang
Guo-Liang Ouyang
Lin Ruan
Mao-Yu Li
Peng-Fei Zhang
Cui Li
Hong Yi
Fang Peng
Jian-Ling Li
Zhu-Chu Chen
Zhi-Qiang Xiao
Publication date
01-12-2009
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 4/2009
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-008-9147-y

Other articles of this Issue 4/2009

Medical Oncology 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.